RecruitingEarly Phase 1NCT05327699

Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine


Sponsor

Emory University

Enrollment

140 participants

Start Date

Nov 8, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The main purpose of this study is to investigate the effects of ketamine on decision-making and emotion processing in a sample of individuals diagnosed with Major Depressive Disorder (MDD).


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating how the brain chemical glutamate responds to stress, and whether this response is linked to loss of pleasure (anhedonia) and how well ketamine works as a treatment for severe depression. **You may be eligible if...** - You are 18–65 years old - You have been diagnosed with moderate to severe major depression (MDD) and are not currently taking antidepressants (must be off for at least 8 weeks) - Healthy volunteers without psychiatric conditions are also welcome **You may NOT be eligible if...** - You have a history of bipolar disorder, psychosis, or schizophrenia - You have a substance use disorder within the last 6 months - You have active suicidal thoughts - You have had a bad reaction to ketamine before - You are pregnant or breastfeeding - You smoke regularly or use recreational drugs - You have certain medical conditions such as uncontrolled high blood pressure or MRI contraindications Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

A single intravenous (IV) infusion of ketamine calculated at 0.5mg/kg through an indwelling catheter over a 40-100min period.

OTHERPlacebo

A single intravenous (IV) infusion of saline through an indwelling catheter over a 40-100min period.


Locations(1)

Emory University

Atlanta, Georgia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05327699


Related Trials